Showing results (31-40 of 2,599) with videos related to
Sort By:
Pageof 260
Archives of General Psychiatry|June 1, 1990
Circadian variation of plasma homovanillic acid levels is attenuated by fluphenazine in patients with schizophreniaA R Doran, R Labarca, O M Wolkowitz, et al.Journal of Affective Disorders|March 1, 1986
Pre- and post-dexamethasone plasma ACTH levels in depressed patients and normal controlsA Roy, P Gold, D Pickar, et al.Acta Psychiatrica Scandinavica|September 1, 1989
Diazepam-binding inhibitor and corticotropin-releasing hormone in cerebrospinal fluidA Roy, D Pickar, P Gold, et al.Biological Psychiatry|February 15, 1989
Fluphenazine treatment reduces CSF somatostatin in patients with schizophrenia: correlations with CSF HVAA R Doran, D R Rubinow, O M Wolkowitz, et al.European Journal of Pharmacology|April 2, 1986
Chronic corticosterone administration in rats: behavioral and biochemical evidence of increased central dopaminergic activityO Wolkowitz, M Sutton, M Koulu, et al.Science (New York, N.Y.)|August 31, 1984
Neuroleptic-induced decrease in plasma homovanillic acid and antipsychotic activity in schizophrenic patientsD Pickar, R Labarca, M Linnoila, et al.Archives of General Psychiatry|March 1, 1985
Atrophy limited to the third ventricle in chronic schizophrenic patients. Report of a controlled seriesJ Boronow, D Pickar, P T Ninan, et al.Trends in Pharmacological Sciences|February 13, 2001
Pharmacogenomics of psychiatric disordersD Pickar, K RubinowPsychological Medicine|May 1, 1985
CSF monoamine metabolites in chronic schizophrenic patients who attempt suicideA Roy, P Ninan, A Mazonson, et al.The Psychiatric Clinics of North America|September 1, 1983
The measurement of endorphins in body fluidsD Naber, D PickarPageof 260